Siham Imani
Director/Board Member at ASCENDIS PHARMA A/S
Net worth: - $ as of 2024-03-30
Profile
Siham Imani is an Independent Director at Ascendis Pharma A.
They are also the Head of Global Strategy & Business Development at CHIESI Farmaceutici SpA.
Prior to their current positions, Ms. Imani served as the EVP of Corporate Strategy & Business Development at Servier SAS.
They previously worked as a Project Director at Pierre Fabre Médicament SAS, VP of the European Business Unit Pediatric Endocrinology at Ipsen SA, and Manager of Marketing & Clinical at Biosense Webster France.
Ms. Imani holds an MBA from Stanford University and a graduate degree from Ecole Polytechnique.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ASCENDIS PHARMA A/S
-.--% | 2023-12-30 | 0 ( -.--% ) | - $ | 2024-03-30 |
Siham Imani active positions
| Companies | Position | Start |
|---|---|---|
| ASCENDIS PHARMA A/S | Director/Board Member | 2022-08-31 |
Servier SAS
 Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Corporate Officer/Principal | 2016-12-31 |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Corporate Officer/Principal | - |
Former positions of Siham Imani
| Companies | Position | End |
|---|---|---|
| IPSEN | Corporate Officer/Principal | 2017-03-31 |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | 2010-12-31 |
| Biosense Webster France | Sales & Marketing | 2009-12-31 |
Training of Siham Imani
| Stanford University | Masters Business Admin |
| Ecole Polytechnique | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IPSEN | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| Private companies | 4 |
|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Health Technology |
Pierre Fabre Médicament SAS
Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| Biosense Webster France | |
Servier SAS
Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Commercial Services |
- Stock Market
- Insiders
- Siham Imani
